Data gathered: December 23
AI Stock Analysis - LabCorp (LH)
Analysis generated October 23, 2024. Powered by Chat GPT.
Laboratory Corporation of America Holdings, commonly known as LabCorp, is an American healthcare company that operates one of the largest clinical laboratory networks in the world. The company offers a broad range of diagnostic services, including tests for various diseases and medical conditions. LabCorp's services are essential for both healthcare providers and patients, providing critical data to guide treatment decisions.
Stock Alerts - LabCorp (LH)
 |
LabCorp | December 5 Insider Alert: Gilliland Dwight Gary is selling shares |
|
LabCorp | November 27 Insider Alert: Summy Amy B. is selling shares |
|
LabCorp | November 26 Insider Alert: van der Vaart Sandra D is selling shares |
|
LabCorp | November 14 Insider Alert: Schechter Adam H is selling shares |
Alternative Data for LabCorp
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 1,000 | Sign up | Sign up | Sign up |
| Sentiment | 50 | Sign up | Sign up | Sign up |
| Webpage traffic | 14,632,000 | Sign up | Sign up | Sign up |
| Employee Rating | 70 | Sign up | Sign up | Sign up |
| Google Trends | 77 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 93 | Sign up | Sign up | Sign up |
| Facebook Followers | 13,918 | Sign up | Sign up | Sign up |
| Instagram Followers | 11,045 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 2,057 | Sign up | Sign up | Sign up |
| Twitter Followers | 7,924 | Sign up | Sign up | Sign up |
| Twitter Mentions | 18 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 6,040 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | 26 | Sign up | Sign up | Sign up |
| Business Outlook | 59 | Sign up | Sign up | Sign up |
| Linkedin Employees | 37,643 | Sign up | Sign up | Sign up |
About LabCorp
Laboratory Corp. of America Holdings is a clinical laboratory company, which engages in the provision of clinical laboratory and end-to-end drug development services. It operates through the LabCorp Diagnostics and Covance Drug Development segments. The LabCorp Diagnostics segment includes core testing as well as genomic and esoteric testing. The Covance Drug Development segment involves in providing drug development solutions, to companies in the pharmaceutical and biotechnology industries.
| Price | $227.84 |
| Target Price | Sign up |
| Volume | 510,370 |
| Market Cap | $19.1B |
| Year Range | $191.32 - $245.48 |
| Dividend Yield | 1.26% |
| PE Ratio | 43.3 |
| Analyst Rating | 73% buy |
| Industry | Health Care Services |
In the news
 |
Laboratory Co. of America Holdings (NYSE:LH) Given Average Rating of “Moderate Buy” by BrokeragesDecember 20 - ETF Daily News |
 |
LH Stock May Gain From Select MAWD Pathology Asset Purchase DealDecember 16 - Yahoo |
|
HighTower Advisors LLC Trims Stock Holdings in Laboratory Co. of America Holdings (NYSE:LH)December 10 - ETF Daily News |
|
Townsquare Capital LLC Sells 430 Shares of Laboratory Co. of America Holdings (NYSE:LH)December 3 - ETF Daily News |
|
2,667 Shares in Laboratory Co. of America Holdings (NYSE:LH) Purchased by Quantbot Technologies LPDecember 3 - ETF Daily News |
|
The Manufacturers Life Insurance Company Sells 1,517 Shares of Laboratory Co. of America Holdings (NYSE:LH)December 3 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 3.28B | 2.38B | 904M | 169M | 324M | 3.500 |
| Q2 '24 | 3.22B | 2.29B | 926M | 205M | 377M | 3.940 |
| Q1 '24 | 3.18B | 2.28B | 897M | 228M | 404M | 3.680 |
| Q4 '23 | 3.03B | 2.21B | 821M | -167M | -32M | 3.300 |
| Q3 '23 | 3.06B | 2.21B | 851M | 183M | 344M | 3.380 |
Insider Transactions View All
| Gilliland Dwight Gary filed to sell 7,712 shares at $241. December 4 '24 |
| EISENBERG GLENN A filed to sell 31,289 shares at $240.4. December 4 '24 |
| Summy Amy B. filed to sell 4,319 shares at $238.9. November 26 '24 |
| Van Der Vaart Sandra D filed to sell 2,670 shares at $239.4. November 25 '24 |
| Schechter Adam H filed to sell 87,441 shares at $243.5. November 13 '24 |
Similar companies
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| John James |
Sep 2, 24 | Buy | $1K - $15K |
| Ro Khanna |
Jul 8, 24 | Buy | $1K - $15K |
| Rohit Khanna Democrat |
Jun 5, 24 | Buy | $1K - $15K |
Read more about LabCorp (LH) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of LabCorp?
The Market Cap of LabCorp is $19.1B.
What is LabCorp's PE Ratio?
As of today, LabCorp's PE (Price to Earnings) ratio is 43.3.
What is the current stock price of LabCorp?
Currently, the price of one share of LabCorp stock is $227.84.
How can I analyze the LH stock price chart for investment decisions?
The LH stock price chart above provides a comprehensive visual representation of LabCorp's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling LabCorp shares. Our platform offers an up-to-date LH stock price chart, along with technical data analysis and alternative data insights.
Does LH offer dividends to its shareholders?
Yes, LabCorp (LH) offers dividends to its shareholders, with a dividend yield of 1.26%. This dividend yield represents LabCorp's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering LabCorp in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
What are some of the similar stocks of LabCorp?
Some of the similar stocks of LabCorp are Abbott Laboratories, HCA Healthcare, Cardinal Health, Henry Schein, and Idexx Laboratories.
.